LMR Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	–	–	860
2023 Q4	–	Hold	0	–	–	–	768
2023 Q3	–	Hold	0	–	–	–	807
2021 Q2	–	Sell	-25,000	Closed	-$642K	–	1223
2021 Q1	$642K	Buy	+25,000	New	+$642K	0.02%	576